遗传风险、生活方式与年龄相关性黄斑变性:EYE-RISK联盟研究
结果显示晚期AMD患者中89%总遗传风险评分为正,ARMS2与补体通路最为突出,而不利生活方式在各遗传风险等级中均使晚期AMD风险至少增加2倍。
要点
- 晚期AMD患者中89%(1581/1777)总遗传风险评分为正,风险评分随AMD严重程度升高。
- ARMS2与补体通路是最主要的遗传通路,但35%晚期患者同时存在3条通路风险。
- 不利生活方式在各遗传风险等级中均使晚期AMD风险至少增加2倍。
核心结论
- 遗传风险变异在多数晚期AMD患者中起作用,但生活方式对遗传风险结局有强影响,应成为患者管理的重点。
研究设计与样本
- AMD基于眼底照相诊断和分级,遗传、生活方式和饮食数据经统一 harmonization 处理。
主要发现
- 晚期AMD患者与对照差异最大且人群归因分数最高的风险变异位于ARMS2(rs3750846)和CFH(rs570618、rs10922109)。
- 总遗传风险评分范围为-3.50至4.63,并随AMD严重程度升高。
- 晚期AMD患者中1581/1777(89%)总遗传风险评分为正。
- 补体通路和ARMS2是晚期AMD最突出的遗传通路(90%晚期患者该通路风险评分为正),但35%晚期患者存在3条通路风险。
- 生活方式在每个遗传风险类别中均为结局的强决定因素,不利生活方式使晚期AMD风险至少增加2倍。
关键数值与推荐
- 总遗传风险评分基于SNP剂量和条件β值构建,范围为-3.50至4.63。
- 生活方式评分基于吸烟和饮食构建。
- 晚期AMD患者中89%(1581/1777)总遗传风险评分为正。
- 补体通路和ARMS2风险评分在90%晚期AMD患者中为正。
- 35%晚期AMD患者存在3条通路风险。
临床怎么用
- 在患者管理中应重点关注生活方式因素,因其对遗传风险结局有强影响。
- 遗传风险评分可用于评估AMD风险,ARMS2和补体通路是主要贡献通路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Age-related macular degeneration (AMD) is a common multifactorial disease in the elderly with a prominent genetic basis. Many risk variants have been identified, but the interpretation remains challenging. We investigated the genetic distribution of AMD-associated risk variants in a large European consortium, calculated attributable and pathway-specific genetic risks, and assessed the influence of lifestyle on genetic outcomes. DESIGN: Pooled analysis of cross-sectional data from the European Eye Epidemiology Consortium. PARTICIPANTS: Seventeen thousand one hundred seventy-four individuals 45 years of age or older participating in 6 population-based cohort studies, 2 clinic-based studies, and 1 case-control study. METHODS: Age-related macular degeneration was diagnosed and graded based on fundus photographs. Data on genetics, lifestyle, and diet were harmonized. Minor allele frequencies and population-attributable fraction (PAF) were calculated. A total genetic risk score (GRS) and pathway-specific risk scores (complement, lipid, extra-cellular matrix, other) were constructed based on the dosage of SNPs and conditional β values; a lifestyle score was constructed based on smoking and diet. MAIN OUTCOME MEASURES: Intermediate and late AMD. RESULTS: The risk variants with the largest difference between late AMD patients and control participants and the highest PAFs were located in ARMS2 (rs3750846) and CHF (rs570618 and rs10922109). Combining all genetic variants, the total genetic risk score ranged from -3.50 to 4.63 and increased with AMD severity. Of the late AMD patients, 1581 of 1777 (89%) showed a positive total GRS. The complement pathway and ARMS2 were by far the most prominent genetic pathways contributing to late AMD (positive GRS, 90% of patients with late disease), but risk in 3 pathways was most frequent (35% of patients with late disease). Lifestyle was a strong determinant of the outcome in each genetic risk category; unfavorable lifestyle increased the risk of late AMD at least 2-fold. CONCLUSIONS: Genetic risk variants contribute to late AMD in most patients. However, lifestyle factors have a strong influence on the outcome of genetic risk and should be a strong focus in patient management. Genetic risks in ARMS2 and the complement pathway are present in most late AMD patients but are mostly combined with risks in other pathways.
引用
- Colijn JM, Meester-Smoor M, Verzijden T, et al. Genetic Risk, Lifestyle, and Age-Related Macular Degeneration in Europe: The EYE-RISK Consortium. Ophthalmology. 2020. PMID: 33253757. doi:10.1016/j.ophtha.2020.11.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。